Arrowstreet Capital
RIGL icon

Arrowstreet Capital’s Rigel Pharmaceuticals RIGL Stock Holding History

Arrowstreet Capital’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.52M Sell
167,342
-246,317
-60% -$8.28M ﹤0.01% 1191
2025
Q4 		$17.7M Buy
413,659
+227,333
+122% +$8.57M 0.01% 771
2025
Q3 		$5.28M Buy
186,326
+164,343
+748% +$4.92M ﹤0.01% 1158
2025
Q2 		$412K Buy
+21,983
New +$417K ﹤0.01% 1783
2021
Q4 		– Sell
-13,739
Closed -$499K – 1674
2021
Q3 		$499K Buy
+13,739
New +$541K ﹤0.01% 1418
2021
Q1 		– Sell
-126,056
Closed -$4.41M – 2482
2020
Q4 		$4.41M Sell
126,056
-42,026
-25% -$1.22M 0.01% 1245
2020
Q3 		$4.03M Buy
168,082
+57,557
+52% +$1.41M 0.01% 1246
2020
Q2 		$2.02M Buy
+110,525
New +$1.99M ﹤0.01% 1475

Other funds holding RIGL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return